Liz Cheney was furious when CNN made this shocking

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
254
Liz Cheney was furious when CNN made this shocking prediction

Liz Cheney has become Nancy Pelosi’s favorite Republican.

She’s leading the witch hunt against Donald Trump.

And Liz Cheney was furious when CNN made this shocking prediction.

Even though Wyoming Congresswoman Liz Cheney represents one of the most conservative states in the country, she turned her back on her constituents by voting to impeach President Trump and joining Nancy Pelosi’s sham January 6 Committee.

Instead of focusing on the many failures of Joe Biden, Cheney’s been sucking up to the Democrats and corporate-controlled media.

After establishing herself as the biggest RINO in Congress, she made the curious decision to seek re-election as a Republican.

Wyoming gave Trump his biggest margin of victory of any state in both 2016 and 2020.

After President Trump endorsed attorney Harriet Hageman in the GOP Primary, conservatives have consolidated their support around her.

One of Cheney’s biggest cheerleaders in the corporate-controlled media, CNN, poured cold water on her fantasy of winning re-election.

CNN political analyst Harry Enten compared Cheney’s fate to that of South Carolina Congressman Tom Rice, one of the 10 House Republicans who voted to impeach Trump.

Trump-backed candidate Russell Fry defeated Rice in a recent GOP Primary by a margin of 51.1% to 24.5%.

Host Anderson Cooper asked how things looked for Cheney.

“Well, if you watched what happened in South Carolina, I bet you can guess,” Enten responded.

“On Cheney, if you go over to Wyoming, look at her disapproval rating,” he added. “Essentially, what you see is that it has doubled, more than doubled, gone up 40 points from before she voted to impeach Donald Trump to after voting to impeach Donald Trump.”

CNN displayed a graphic showing Cheney’s disapproval rate in Wyoming went from 26% before she voted for impeachment to 72% today.

Enten said that Cheney is “wildly unpopular” in Wyoming, adding that betting markets give her a roughly 10% chance of winning the Primary.

But based on the recent polling out of Wyoming, even that might be generous.

Two recently released polls had Cheney down by 28% and 30% respectively.

Cooper asked former top Obama strategist David Axelrod what he thought about Cheney’s chances.

Axelrod gave her more bad news about her political future, citing her role as the poster girl for the sham January 6 Committee.

“Well, honestly, every time she speaks at these hearings, she’s probably making her task even more difficult,” Axelrod said. “And I think the one hope they have is that Democrats re-register and crossover in record numbers to support her.”

Since Wyoming has open primaries, Party leaders are encouraging Democrats to crossover and vote for Cheney.

But in the most Republican state in the country, it would take a miracle for enough Democrats to carry Cheney over the finish line.

“But honestly, you heard Harry’s over-caffeinated analysis, but an accurate one. She is in a world of hurt and no sensible person in politics would bet on her re-nomination at this point,” Axelrod concluded.

After betraying conservatives, the GOP Primary appears to be the end of the line for Liz Cheney.


https://renewedright.com/liz-cheney-was-furio...rediction/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Kenmare Resources Welcomes New Dredges to Moma Mine

Updated Category News Views 258

Exciting Developments at the Moma Mine Kenmare Resources plc is a major player in the global mining sector, particularly known for its production of titanium minerals and zircon. Recently, Kenmare achieved a significant milestone with the arrival of its second high-capacity dredge at the Moma Titanium Minerals Mine in northern Mozambique. This advancement represents a...

Continue Reading
Biodesix Reports Strong Q3 2024 Performance and Growth

Updated Category News Views 145

Strong Quarterly Results for Biodesix Biodesix, Inc. (NASDAQ: BDSX), a leader in diagnostic solutions, recently announced impressive financial results for its third quarter, showing remarkable growth compared to the previous year. The company achieved a revenue of $18.2 million, representing a significant 35% increase over Q3 2023. Furthermore, Biodesix's gross profit...

Continue Reading
Innovative Changes at Health In Tech to Boost AI and Revenue

Updated Category News Views 127

Health In Tech Announces Key Leadership Changes Health In Tech (NASDAQ: HIT), a prominent Insurtech platform company known for its innovative third-party AI technology, has implemented significant leadership changes aimed at reinforcing its AI capabilities and propelling company growth. This strategic move is expected to position the company more competitively in the...

Continue Reading
Urgent Notice for KinderCare Learning Investors: Act Now!

Updated Category News Views 169

Important Alert for KinderCare Learning Investors KinderCare Learning Companies, Inc. (NYSE: KLC) is under scrutiny following a significant decline in its stock prices attributed to serious allegations about the company’s operations. The Allegations: What We Know The company conducted its IPO in 2024, offering more than 27 million shares at $24 per share. However,...

Continue Reading
Replimune Group Faces Class Action Lawsuit - Key Details

Updated Category News Views 148

Replimune Group, Inc. Faces Legal Action Replimune Group, Inc. has recently come under the scrutiny of a class action securities lawsuit. This legal action is initiated by Levi & Korsinsky, a law firm known for its role in securities litigation. The lawsuit targets investors who may have experienced losses due to alleged misleading information regarding the company's...

Continue Reading